FMP

FMP

Enter

TCRX - TScan Therapeutics, Inc.

Valuation of TScan Therapeutics, Inc.(TCRX), TScan Therapeutics, Inc., a preclinical-stage biopharmaceutical company, develops T cell receptor-en

Valuation Date:

Mar 28, 2024 3:00 PM

Share Price on Valuation Date

$7.94

Stock Beta

0.862

Shares Outstanding

43605600

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep